Cleotilde V. Zamora, NP

Cleotilde Zamora practices at Exer Urgent Care - El Segundo in El Segundo, California.

Cleotilde Zamora's NPI, 1821545070, was assigned on September 6, 2016. Cleotilde Zamora holds California license 95004721.

Cleotilde Zamora's primary practice is Exer Urgent Care - El Segundo, at 2361 Rosecrans Ave, El Segundo, CA 90245. The practice phone is (818) 880-2225.

Cleotilde Zamora's primary practice is Exer Urgent Care - El Segundo in El Segundo, California. The medical group on file is Exer Urgent Care. Dmand AI also links Cleotilde Zamora to 1 more medical group, named with a free account. Cleotilde Zamora's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Cleotilde Zamora practices. Vendor and product names are available with a free account.

Family is Cleotilde Zamora's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Cleotilde Zamora is licensed in California.

CMS data shows 240 Medicare services from Cleotilde Zamora across 9 procedure codes in 2024, for 150 Medicare patients. Medicare paid $15,824 for them. Every service was in an office.

CMS counts 150 Medicare patients who saw Cleotilde Zamora in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Cleotilde Zamora's median patient age at 38, with 59% women.

In 2024, Cleotilde Zamora wrote 418 Medicare Part D claims for 225 patients. 90% of them were for generic drugs. CMS names the drug for 319 of them, across 12 drugs with 11 or more claims each, at $2,300 in total drug cost.

Cleotilde Zamora accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Cleotilde Zamora from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $63.